Prolonged corticosteroid therapy and lung abnormalities in patients after severe COVID-19 pneumonia
Anja Ljilja Posavec, Daria Cvetković Kučić, Nikola Zagorec, Linda Malnar, Kristina Lalić, Marina Zelenika, Ivona Kovačević, Dinka Kušter, Andreja Mutvar, Nevenka Piskač Ž ivković · 2024
Read Prolonged corticosteroid therapy and lung abnormalities in patients after severe COVID-19 pneumonia by Anja Ljilja Posavec, Daria Cvetković Kučić, Nikola Zagorec, Linda Malnar, Kristina Lalić, Marina Zelenika, Ivona Kovačević, Dinka Kušter, Andreja Mutvar, Nevenka Piskač Ž ivković (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11708960.txt.
Description
Anja Ljilja Posavec and nine co-authors present a 2024 study on whether long courses of steroids help lungs recover after severe COVID-19 pneumonia. Some survivors keep low oxygen and scarred-looking scans, and immune overreaction was blamed. Patients with lingering breathing failure were followed for three months in three groups: steroids for two weeks, steroids for three months, or no extra steroids. Lung function, symptoms, and CT abnormalities were compared.
The long steroid course brought no benefit: scans, lung function, and recovery looked no better than with short treatment or none. The untreated group actually reported less breathlessness and showed better gas transfer. The authors conclude supplementary steroids do not improve lung outcomes after severe COVID pneumonia with persistent problems. The result argues against extending steroid therapy on speculation alone.
Catalog record
| CREATOR | Anja Ljilja Posavec, Daria Cvetković Kučić, Nikola Zagorec, Linda Malnar, Kristina Lalić, Marina Zelenika, Ivona Kovačević, Dinka Kušter, Andreja Mutvar, Nevenka Piskač Ž ivković |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 29 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |